WO2002008415A1 - Procede de criblage de l'activite de promoteurs ou d'inhibiteurs du ptp$g(j) - Google Patents
Procede de criblage de l'activite de promoteurs ou d'inhibiteurs du ptp$g(j) Download PDFInfo
- Publication number
- WO2002008415A1 WO2002008415A1 PCT/JP2001/006343 JP0106343W WO0208415A1 WO 2002008415 A1 WO2002008415 A1 WO 2002008415A1 JP 0106343 W JP0106343 W JP 0106343W WO 0208415 A1 WO0208415 A1 WO 0208415A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ptpz
- inhibitor
- pleiotrophin
- activity promoter
- extent
- Prior art date
Links
- 101100522321 Rattus norvegicus Ptprz1 gene Proteins 0.000 title abstract 5
- 230000000694 effects Effects 0.000 title abstract 4
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000012216 screening Methods 0.000 title 1
- 108090000368 Fibroblast growth factor 8 Proteins 0.000 abstract 3
- 102000005162 pleiotrophin Human genes 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 210000005036 nerve Anatomy 0.000 abstract 2
- 239000003053 toxin Substances 0.000 abstract 2
- 231100000765 toxin Toxicity 0.000 abstract 2
- 241000590002 Helicobacter pylori Species 0.000 abstract 1
- 208000007107 Stomach Ulcer Diseases 0.000 abstract 1
- 230000004308 accommodation Effects 0.000 abstract 1
- 201000005917 gastric ulcer Diseases 0.000 abstract 1
- 229940037467 helicobacter pylori Drugs 0.000 abstract 1
- 238000011813 knockout mouse model Methods 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 230000035790 physiological processes and functions Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000004043 responsiveness Effects 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0356—Animal model for processes and diseases of the central nervous system, e.g. stress, learning, schizophrenia, pain, epilepsy
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0368—Animal model for inflammation
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0393—Animal model comprising a reporter system for screening tests
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Environmental Sciences (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biodiversity & Conservation Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plant Pathology (AREA)
- Animal Husbandry (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE60144563T DE60144563D1 (de) | 2000-07-24 | 2001-07-23 | Verfahren zum screening der promoteraktivität oder eines hemmstoffs von ptp zeta |
JP2002513898A JP3785460B2 (ja) | 2000-07-24 | 2001-07-23 | PTPζ活性促進又は抑制物質のスクリーニング方法 |
EP01950037A EP1306429B1 (en) | 2000-07-24 | 2001-07-23 | Method of screening ptp zeta activity promoter or inhibitor |
US10/333,786 US7166761B2 (en) | 2000-07-24 | 2001-07-23 | Method of screening PTPζ activity promoter or inhibitor |
CA002418267A CA2418267C (en) | 2000-07-24 | 2001-07-23 | Method of screening ptp zeta activity promoter or inhibitor |
US11/639,343 US20070079389A1 (en) | 2000-07-24 | 2006-12-15 | Method for screening PTPzeta activity promoter or inhibitor |
US12/420,639 US20100287626A1 (en) | 2000-07-24 | 2009-04-08 | Method of screening ptp zeta activity promoter or inhibitor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-223184 | 2000-07-24 | ||
JP2000223184 | 2000-07-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002008415A1 true WO2002008415A1 (fr) | 2002-01-31 |
Family
ID=18717315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2001/006343 WO2002008415A1 (fr) | 2000-07-24 | 2001-07-23 | Procede de criblage de l'activite de promoteurs ou d'inhibiteurs du ptp$g(j) |
Country Status (6)
Country | Link |
---|---|
US (3) | US7166761B2 (ja) |
EP (1) | EP1306429B1 (ja) |
JP (1) | JP3785460B2 (ja) |
CA (1) | CA2418267C (ja) |
DE (1) | DE60144563D1 (ja) |
WO (1) | WO2002008415A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004092371A1 (ja) * | 2003-04-18 | 2004-10-28 | Japan Science And Technology Agency | グルタミン酸トランスポーターglast機能欠損マウス |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9277737B2 (en) | 2006-09-21 | 2016-03-08 | Probiodrug Ag | Mouse models carrying a knock-out mutation of the QPCTL-gene |
EP2432314B1 (en) * | 2009-05-19 | 2017-12-20 | Probiodrug AG | Mouse models carrying a knock-out mutation of the qpctl-gene |
CN106957892A (zh) * | 2016-01-08 | 2017-07-18 | 中国科学院生态环境研究中心 | 一种用于蛋白质酪氨酸磷酸酶活性的免标记电化学传感检测方法 |
KR102234449B1 (ko) * | 2019-04-04 | 2021-03-30 | 재단법인대구경북과학기술원 | 불안 장애 예방 또는 치료를 위한 PTPσ 유전자 및 이를 이용한 스크리닝 방법 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030106083A1 (en) * | 2000-12-06 | 2003-06-05 | Allen Keith D. | Transgenic mice containing RPTPB tyrosine phosphatase gene disruptions |
-
2001
- 2001-07-23 DE DE60144563T patent/DE60144563D1/de not_active Expired - Lifetime
- 2001-07-23 US US10/333,786 patent/US7166761B2/en not_active Expired - Fee Related
- 2001-07-23 WO PCT/JP2001/006343 patent/WO2002008415A1/ja active Application Filing
- 2001-07-23 JP JP2002513898A patent/JP3785460B2/ja not_active Expired - Fee Related
- 2001-07-23 CA CA002418267A patent/CA2418267C/en not_active Expired - Fee Related
- 2001-07-23 EP EP01950037A patent/EP1306429B1/en not_active Expired - Lifetime
-
2006
- 2006-12-15 US US11/639,343 patent/US20070079389A1/en not_active Abandoned
-
2009
- 2009-04-08 US US12/420,639 patent/US20100287626A1/en not_active Abandoned
Non-Patent Citations (5)
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004092371A1 (ja) * | 2003-04-18 | 2004-10-28 | Japan Science And Technology Agency | グルタミン酸トランスポーターglast機能欠損マウス |
JPWO2004092371A1 (ja) * | 2003-04-18 | 2006-07-06 | 独立行政法人科学技術振興機構 | グルタミン酸トランスポーターglast機能欠損マウス |
US7642399B2 (en) | 2003-04-18 | 2010-01-05 | Japan Science And Technology Agency | Mouse with deficiency of glutamate transporter GLAST function |
JP4494340B2 (ja) * | 2003-04-18 | 2010-06-30 | 独立行政法人科学技術振興機構 | グルタミン酸トランスポーターglast機能欠損マウス |
Also Published As
Publication number | Publication date |
---|---|
US7166761B2 (en) | 2007-01-23 |
CA2418267C (en) | 2007-09-18 |
US20030186284A1 (en) | 2003-10-02 |
US20070079389A1 (en) | 2007-04-05 |
DE60144563D1 (de) | 2011-06-16 |
CA2418267A1 (en) | 2003-01-23 |
EP1306429A1 (en) | 2003-05-02 |
JP3785460B2 (ja) | 2006-06-14 |
EP1306429B1 (en) | 2011-05-04 |
EP1306429A4 (en) | 2005-01-26 |
US20100287626A1 (en) | 2010-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hyne et al. | Invertebrate biomarkers: links to toxicosis that predict population decline | |
Wardle et al. | Plant removals in perennial grassland: vegetation dynamics, decomposers, soil biodiversity, and ecosystem properties | |
Proffitt et al. | Linking landscape‐scale differences in forage to ungulate nutritional ecology | |
Hebert et al. | Stable nitrogen isotopes in waterfowl feathers reflect agricultural land use in western Canada | |
Zhang et al. | Changes in enzyme activities of spruce (Picea balfouriana) forest soil as related to burning in the eastern Qinghai-Tibetan Plateau | |
Newton et al. | Selective grazing modifies previously anticipated responses of plant community composition to elevated CO2 in a temperate grassland | |
Brook et al. | Would the Australian megafauna have become extinct if humans had never colonised the continent? Comments on “A review of the evidence for a human role in the extinction of Australian megafauna and an alternative explanation” by S. Wroe and J. Field | |
Evans et al. | The asymmetrical cost of tail elongation in red-billed streamertails | |
Hebert et al. | Mercury trends in colonial waterbird eggs downstream of the oil sands region of Alberta, Canada | |
Pratte et al. | Four sympatrically nesting auks show clear resource segregation in their foraging environment | |
Kollasch et al. | Leaf vibrations produced by chewing provide a consistent acoustic target for plant recognition of herbivores | |
Amira et al. | Measure of environmental stress biomarkers in Donax trunculus (Mollusca, Bivalvia) from the gulf of Annaba (Algeria) | |
WO2003047428A3 (en) | Apparatus and methods for testing pain sensitivity | |
WO2002008415A1 (fr) | Procede de criblage de l'activite de promoteurs ou d'inhibiteurs du ptp$g(j) | |
Prince et al. | Changes in the vegetation composition of hay meadows between 1993 and 2009 in the Picos de Europa and implications for nature conservation | |
Hixon et al. | Nitrogen isotope (δ15N) patterns for amino acids in lemur bones are inconsistent with aridity driving megafaunal extinction in south‐western Madagascar | |
Jovani et al. | Fault bars timing and duration: the power of studying feather fault bars and growth bands together | |
Hansson et al. | The quality and the timing hypotheses evaluated using data on great reed warblers | |
Bender et al. | Effects of site characteristics, pinyon-juniper management, and precipitation on habitat quality for mule deer in New Mexico | |
Wolf et al. | Ixodes scapularis: vector to an increasing diversity of human pathogens in the upper Midwest | |
WO2001087055A3 (en) | New screening tool for analyzing the behavior of laboratory animals | |
Jay | Iron Age diet at Glastonbury Lake Village: the isotopic evidence for negligible aquatic resource consumption | |
WO2007054937A3 (en) | Decreasing or preventing sub-surface geological matter contamination by agrochemicals | |
Sanchez-Hernandez et al. | Inhibition of plasma butyrylcholinesterase activity in the lizard Gallotia galloti palmae by pesticides: a field study | |
EP1970811A3 (en) | System, method and computer program product for identifying code development errors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): CH DE ES FR GB IT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2418267 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10333786 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001950037 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001950037 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2003131179 Country of ref document: RU Kind code of ref document: A Format of ref document f/p: F |